Clinical medication
In the journey of innovative drug development, the management of clinical trial materials is a critical link that determines the success and compliance of the research. As a professional pharmaceutical distributor, we are committed to providing pharmaceutical companies, biotech firms, and CROs with efficient, compliant, and precise one-stop solutions for clinical trial drug supplies, facilitating the smooth progress of your R&D projects.
Our Core Services & Value
01 End-to-End Professional Management:
We provide comprehensive services spanning from drug reception, storage, labeling, and packaging to direct delivery to clinical trial sites nationwide. Strictly adhering to GCP and GSP standards, we ensure traceability and quality safety at every step of the process.
02 Precision Supply Chain Services:
We deeply understand the specific requirements of clinical trials (designated patient, site, quantity, and drug). Through professional project management and a real-time inventory system, we ensure accurate and timely drug delivery, while efficiently handling returns and destruction processes to guarantee data integrity.
03 Customized Solution Capability:
We can flexibly meet complex needs such as double-blind trials, blinded packaging, emergency unblinding, and central pharmacy depot management. We provide personalized packaging solutions and flexible distribution strategies tailored to your unique study design.
04 Compliance & Risk Management:
Our experienced quality assurance team ensures all operations fully comply with the regulatory requirements of the National Medical Products Administration (NMPA), effectively mitigating compliance risks within your supply chain.

By choosing us, you are selecting a professional and reliable R&D partner. We will shoulder the significant responsibility of clinical trial drug supply management with a rigorous approach and efficient execution, allowing you to focus more on core research and development, working together to accelerate the journey of innovative drugs to market.